Pfizer Inc
NYSE: PFE
$28.64
-$0.22 (-0.8%)
Closing Price on October 24, 2024
PFE Articles
Early this week we are running a list of stocks that have been in a turnaround plan, yet the stocks and the businesses haven’t turned around. Could these be the stocks to watch for 2008? Pfizer...
Published:
Last Updated:
Biogen-Iden (NASDAQ:BIIB) is seeing its shares pummeled in after-hours trading. The company didn’t have another biotech drug crisis though. Biogen had been under a corporate strategic review...
Published:
Last Updated:
It is always interesting seeing which groups and which stocks saw the biggest changes in short interest. This list doesn’t show financials because we’ve already shown that individually. Here...
Published:
Last Updated:
According to Reuters, the Fed’s decision to make an October rate cute was a "close call." Reuters writes that Paulson said home loan defaults will be much higher in 2008. Reuters writes that HP’s...
Published:
Pfizer (NYSE:PFE) is seeing additional pressure this afternoon. Apparently the FDA said it is looking into reports that Pfizer has sent out an "early communications notice" to doctors warning them...
Published:
Last Updated:
According to Reuters, Goldman Sachs (GS) issued a report saying the housing sector had much further to fall and that some financial institutions would have to raise money to stay in business. The...
Published:
We have already noted the Van der Moolen (NYSE:VDM) exit of all NYSE Specialist activities and we’ve already covered some of the other key stocks where Van der Moolen acts as a Specialist in the...
Published:
Last Updated:
Pfizer (PFE) has a new ad campaign for its erectile dysfunction drug Viagra. The marketing message is all over TV and in little video clips online. Reuters.com appears to have one of the ads on every...
Published:
Following is the short interest in stocks of major companies traded on the NYSE. Figures are as of October 15 and compare to numbers on September 28, 2007. Most of the large increases and total short...
Published:
IMS Health (RX) Bad numbers and a downgrade. Falls to $21.20 from 52-week high of $33.12. The PMI Group (PMI) Housing and mortgage markets hurt quarter. Falls to $22.80 from 52-week high of $51.46....
Published:
Last Updated:
Nektar Therapeutics (NASDAQ:NKTR) is seeing shares hitting 52-week lows after its pharmaceutical partner Pfizer Inc. (NYSE:PFE) unexpectedly said it would end its involvement in inhaled diabetes drug...
Published:
Pfizer (PFE) posted third-quarter 2007 revenues of $12.0 billion, a 2% decline from the same period last year. The Company’s reported net income was $761 million in the third quarter of 2007, a...
Published:
Pfizer (PFE) is hooking up with doctor social network Sermo. According to The Wall Street Journal: "Pfizer-affiliated doctors will be able to talk candidly with the site’s 31,000 members,...
Published:
According to Reuters, Citigroup (C) and other large banksare planning to create a roughly $80 billion fund to buy ailing mortgage securities and other assets. Reuters writes that Medtronic (MDT) is...
Published:
For Pfizer, it has been a long and painful fall. In early 2004, its shares were just below $39. It was the age of Big Pharma. Most of the big drugs had not gone "off patent" and so there was very...
Published: